Skip to main content

Xencor Inc

XNCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001326732

No open-market purchases or sales by Xencor Inc insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $1.36B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Xencor Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Xencor Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Xencor Inc
NameTitleLast reported holdingLast filingFilings, past year
Feigal EllenDirector22,642Jul 8, 20262
Gorman Kevin CharlesDirector21,680Jul 8, 20262
Gustafson Kurt ADirector25,011Jul 8, 20262
Klencke BarbaraDirector29,974Jul 8, 20261
Montgomery Alan BruceDirector25,849Jul 8, 20262
Ranieri Richard JDirector24,011Jul 8, 20262
Simpson Todd EDirector23,988Jul 8, 20261
Deshaies Raymond JosephDirector10,302Jul 8, 20261
Cornelissen Bart JanSR. VICE PRESIDENT & CFO75,898Apr 13, 20263
Dahiyat Bassil IPRESIDENT & CEO546,316Mar 9, 20263
Desjarlais John RSR. VICE PRESIDENT & CSO263,831Mar 9, 20264
Eckert CeliaSVP, GENERAL COUNSEL76,918Mar 9, 20262
Valente NancyEVP, Chief Development Officer49,169May 6, 20250
Rosa-Bjorkeson DagmarDirector8,490Oct 1, 20240
Kuch John JSR. VICE PRESIDENT & CFO121,070Mar 12, 20240
Yang AllenSR. VICE PRESIDENT & CMO73,364Mar 13, 20230
Hata Yujiro SDirector–Jun 27, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 11, 2025 (view filing)Mar 101 dayDahiyat Bassil IPRESIDENT & CEOSSale−19.7K$13.60−$268.1K−4.1%465.4K after
Mar 11, 2025 (view filing)Mar 101 dayDesjarlais John RSR. VICE PRESIDENT & CSOSSale−9.70K$13.60−$131.9K−3.9%236.6K after
Mar 11, 2025 (view filing)Mar 101 dayEckert CeliaSVP, GENERAL COUNSELSSale−5.74K$13.60−$78.1K−8.3%63.5K after
Mar 11, 2025 (view filing)Mar 101 dayValente NancyEVP, Chief Development OfficerSSale−2.56K$13.60−$34.9K−4.6%53.8K after
Apr 14, 2025 (view filing)Apr 104 daysCornelissen Bart JanSR. VICE PRESIDENT & CFOSSale−3.75K$8.06−$30.2K−5.8%61.3K after
May 6, 2025 (view filing)May 24 daysValente NancyEVP, Chief Development OfficerSSale−4.62K$11.03−$50.9K−8.6%49.2K after
Jun 16, 2025 (view filing)Jun 16Same dayRanieri Richard JDirectorSSale−2.99K$9.22−$27.6K−13.5%19.2K after10b5-1
Jun 16, 2025 (view filing)Jun 16Same dayFeigal EllenDirectorSSale−2.99K$9.22−$27.6K−13.5%19.2K after10b5-1
Jun 16, 2025 (view filing)Jun 16Same dayGorman Kevin CharlesDirectorSSale−3.17K$9.22−$29.3K−14.4%18.9K after10b5-1
Jun 16, 2025 (view filing)Jun 16Same dayGustafson Kurt ADirectorSSale−2.99K$9.22−$27.6K−12.9%20.2K after10b5-1
Jun 16, 2025 (view filing)Jun 16Same dayMontgomery Alan BruceDirectorSSale−2.21K$9.22−$20.4K−9.7%20.6K after10b5-1
Dec 23, 2025 (view filing)Dec 194 daysDahiyat Bassil IPRESIDENT & CEOSSale−114.4K$15.71−$1.80M−19.7%466.6K after
Dec 23, 2025 (view filing)Dec 194 daysDesjarlais John RSR. VICE PRESIDENT & CSOSSale−73.4K$15.72−$1.15M−23.7%236.6K after
Mar 4, 2026 (view filing)Mar 31 dayDahiyat Bassil IPRESIDENT & CEOSSale−6.76K$11.90−$80.4K−1.2%567.8K after
Mar 4, 2026 (view filing)Mar 31 dayDesjarlais John RSR. VICE PRESIDENT & CSOSSale−2.66K$11.90−$31.7K−1.0%270.5K after
Mar 4, 2026 (view filing)Mar 31 dayEckert CeliaSVP, GENERAL COUNSELSSale−1.49K$11.90−$17.8K−1.8%81.9K after
Mar 9, 2026 (view filing)Mar 5-64 daysDahiyat Bassil IPRESIDENT & CEOSSale−21.5K$11.18−$240.1K−3.8%546.3K after2 lots
Mar 9, 2026 (view filing)Mar 5-64 daysDesjarlais John RSR. VICE PRESIDENT & CSOSSale−6.62K$11.16−$73.9K−2.4%263.8K after2 lots
Mar 9, 2026 (view filing)Mar 5-64 daysEckert CeliaSVP, GENERAL COUNSELSSale−5.01K$11.17−$56.0K−6.1%76.9K after2 lots
Mar 9, 2026 (view filing)Mar 54 daysCornelissen Bart JanSR. VICE PRESIDENT & CFOSSale−2.52K$11.25−$28.3K−3.1%79.4K after
Apr 13, 2026 (view filing)Apr 103 daysCornelissen Bart JanSR. VICE PRESIDENT & CFOSSale−3.50K$12.29−$43.0K−4.4%75.9K after
Jun 17, 2026 (view filing)Jun 152 daysGorman Kevin CharlesDirectorSSale−7.53K$12.31−$92.7K−39.8%11.4K after10b5-1
Jun 17, 2026 (view filing)Jun 152 daysRanieri Richard JDirectorSSale−5.47K$12.31−$67.4K−28.5%13.7K after10b5-1
Jun 17, 2026 (view filing)Jun 152 daysMontgomery Alan BruceDirectorSSale−5.06K$12.31−$62.3K−24.6%15.5K after10b5-1
Jun 17, 2026 (view filing)Jun 152 daysGustafson Kurt ADirectorSSale−5.47K$12.31−$67.4K−27.1%14.7K after10b5-1
Jun 22, 2026 (view filing)Jun 184 daysFeigal EllenDirectorSSale−6.84K$13.06−$89.4K−35.7%12.3K after10b5-1